相关实验视频
Updated: Jun 16, 2026

07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
9.9K
开发和验证一个由利益相关者驱动的,独立的电子知情同意平台,用于三组基因组研究研究
Bethany Y Norton1,2, James Liu1,2, Sara A Lewis1,2
1Barrow Neurological Institute, Phoenix Children's, Phoenix, AZ USA.
medRxiv : the preprint server for health sciences
|July 23, 2024
概括
电子知情同意提高了参与者对基因组研究的理解和满意度. 这种数字化方法提高了研究细节的理解和记忆,使复杂的信息更容易获得.
科学领域:
- 基因组学就是基因组学.
- 生物伦理学生物伦理学
- 在知情同意的情况下同意.
背景情况:
- 传统的知情同意过程往往导致参与者的理解和满意度较低.
- 电子同意在临床和研究基因组学中越来越受欢迎,但三组研究的数据有限.
研究的目的:
- 为三组基因组研究设计,开发,实施和验证电子知情同意 (iConsent) 应用程序.
- 在脑基因组研究的背景下,评估参与者对iConsent应用程序的理解和满意度.
主要方法:
- 开发了一个iConsent应用程序,结合了利益相关者的投入和多媒体学习原则.
- 通过交互式回教方法评估参与者的理解能力.
- 对电子同意书的已建立的需要数据进行评估.
主要成果:
- 该iConsent应用程序满足了在基因组研究中有效电子同意的十项建议标准中的九项.
- 参与者表现出高度的理解和保留人类受试者的考虑.
- 报告了参与者的高满意度,与iConsent的清晰度,隐私和研究目标解释有关.
结论:
- 电子知情同意是三组基因组研究的可行和有效方法.
- 该iConsent应用程序提高了参与者的理解和满意度,满足利益相关者的要求.
- 这种数字方法可以增加研究覆盖范围,同时确保对研究协议的强有力的理解.
更多相关视频
相关概念视频
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

